Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC RVX-208 1044870-39-4 20mg
Supplier: Apexbio Technology LLC B149920
RVX-208 (CAS 1044870-39-4) is a small-molecule inhibitor targeting BET (bromodomain and extra-terminal) proteins It is designed to selectively inhibit the binding of BET bromodomains to acetylated lysine residues thereby modulating transcriptional regulation RVX-208 exerts its biological activity primarily through competitive inhibition of the second bromodomain (BD2) of BET proteins In in vitro studies using human hepatic (HepG2) cells RVX-208 demonstrates BD2 inhibitory activity with an IC50 value of 0 51 M and lower affinity for BD1 (IC50 87 M) Based on these pharmacological properties RVX-208 holds research potential in lipid metabolism cholesterol efflux and atherosclerotic disease processes
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?